Skip to content

Clinical effect of pressing acupuncture on patients with chronic rhinosinusitis after endoscopic sinus opening

Clinical effect of pressing acupuncture on patients with chronic rhinosinusitis after endoscopic sinus opening

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200059433
Enrollment
Unknown
Registered
2022-04-25
Start date
2022-05-01
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic sinusitis

Interventions

Control group:Sinus opening + acupuncture simulation operation
Experimental group:Sinus Open Surgery + Acupuncture Treatment

Sponsors

Yuyao People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. A patient diagnosed with chronic sinusitis based on clinical manifestations and laboratory indicators without the knowledge of two chief physicians; 2. The course of chronic sinusitis is more than 1 year, and the symptoms are not improved after >= 12 weeks of standardized drug treatment; 3. Have surgical indications and are willing to accept open sinus surgery; 4. Age 18-65 years old, gender is not limited; 5. The subjects voluntarily signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Diagnosed with or combined with fungal sinusitis, nasopharyngeal hemangioma and nasal cavity malignancy, etc.; 2. Patients with orbital and nasal skull base lesions, such as periorbital cellulitis, intraorbital cellulitis, orbital abscess, meningioma, aneurysmal bone cyst, etc.; 3. Patients with severe organ insufficiency or blood system diseases with surgical contraindications; 4. Other systemic diseases require long-term use of glucocorticoids, antibacterial drugs, antihistamines, and anti-leukotriene drugs; 5. Those who have received nasal endoscopic surgery in the past; 6. Pregnant and lactating women; 7. Those who have a local allergic reaction to the needle; 8. Patients with poor compliance.

Design outcomes

Primary

MeasureTime frame
Clinical efficacy judgment;Quality of life assessment;Nasal symptom score;

Countries

China

Contacts

Public ContactFu Jinya

Yuyao People's Hospital

88509139@qq.com+86 13884407199

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026